Eli Lilly, a leading pharmaceutical company, has filed lawsuits against four telehealth startups for allegedly selling knockoff versions of its GLP-1 medications Mounjaro and Zepbound. These medications, essential for treating obesity and diabetes, generated over $16.4 billion in revenue for… Read More ›